# Stéphane Champiat

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stephane-champiat/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,293 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 47 |
| i10-index | 105 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5060793722 |
| ORCID iD | https://orcid.org/0000-0002-0741-2118 |
| Works | 490 |

## Researcher papers

- [Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy](https://scholariq.org/papers/hyperprogressive-disease-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Renal toxicities associated with pembrolizumab](https://scholariq.org/papers/renal-toxicities-associated-with-pembrolizumab/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.